These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22593016)

  • 1. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
    Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
    Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.
    Ceder JA; Jansson L; Ehrnström RA; Rönnstrand L; Abrahamsson PA
    Eur Urol; 2008 Mar; 53(3):524-31. PubMed ID: 18053634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
    Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
    Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133, a novel marker for human prostatic epithelial stem cells.
    Richardson GD; Robson CN; Lang SH; Neal DE; Maitland NJ; Collins AT
    J Cell Sci; 2004 Jul; 117(Pt 16):3539-45. PubMed ID: 15226377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial model.
    Drewa T; Styczynski J
    Int Urol Nephrol; 2007; 39(3):851-7. PubMed ID: 17318344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133+ renal progenitor cells contribute to tumor angiogenesis.
    Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G
    Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.
    Yin S; Li J; Hu C; Chen X; Yao M; Yan M; Jiang G; Ge C; Xie H; Wan D; Yang S; Zheng S; Gu J
    Int J Cancer; 2007 Apr; 120(7):1444-50. PubMed ID: 17205516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.